Tucson, AZ -- January 22, 2018 -- Critical Path Institute (C-Path) announced today that the European Medicines Agency (EMA) has issued a Letter of Support for measurement of glutamate dehydrogenase ...

Global initiative to scale advanced therapeutic treatments to accelerate patient access worldwide. TUCSON, Ariz. and AMSTERDAM, March 26, 2026 /PRNewswire/ -- Critical Path Institute® (C-Path) today ...

TUCSON, Ariz.--(BUSINESS WIRE)--Critical Path Institute (C-Path) announced today that Dr. Carolyn Compton has joined the organization as its new president and chief executive officer. Dr. Compton ...

TUCSON, Ariz., April 28, 2026 — Critical Path Institute® (C-Path) today announced a $456,000 grant to James Shayman, M.D., at the University of Michigan, to support development of a brain-penetrant ...

TUCSON, Ariz., Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute, an independent, non-profit that catalyzes innovative ideas that accelerate the speed of drug and medical product ...

TUCSON, Ariz. (KVOA) — It's been a Tucson based non-profit for two decades. Critical path institute also known as c-path plays a major role in advancing drug development all over the world. Critical ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

About Critical Path Institute Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership in response to the FDA's Critical Path Initiative.

To help close this gap, One to Millions advances the U.S. Food and Drug Administration (FDA) Plausible Mechanism Framework and Rare Disease Evidence Principles by leveraging C-Path's centralized, ...